SelfCog®: A 15-min Digitized Cognitive Battery To Measure Cognitive Deficit In Parkinson Disease (PD) Patients
Objective: Use a news automated, motor-controlled cognitive battery, the SelfCog®, to compare cognitive deficits in PD patients. Background: Mild cognitive impairment (MCI) is a major…How Does Mild Cognitive Impairment in Parkinson’s Disease Affect Communication Abilities?
Objective: We explored differences in communication abilities in people with Parkinson’s disease (PwP) with mild cognitive impairment (MCI) (PwP-MCI) and those with normal cognition (PwP-CN).…Blood Pressure Profile of PD-MCI and PDD in Parkinson’s Disease Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Objective: This study aims to explore the BP profile in both PD-MCI and PDD Background: Blood pressure (BP) abnormality is often correlated with cognitive impairment. However,…The effects of DL-3-n-butylphthalide in patients with mild cognitive impairment due to Parkinson’s disease: A multicenter, randomized, double-blind, placebo-controlled trial
Objective: To assess the therapeutic effect of DL-3-n-butylphthalide on cognitive impairment associated with Parkinson’s disease (PD). Background: PD associated cognitive impairment are attracting attention because…Alterations in neural processes of cognitive control in asymptomatic heterozygous mutation carriers in the Parkin gene
Objective: Investigating heterozygous Parkin gene (PRKN) mutation carriers to evaluate the potential association of this mutation with an alteration of cognitive control processes. Background: Recessively…Disease Progression in Patients with PLA2G6-related Parkinsonism: A Longitudinal Study
Objective: To investigate disease progression of PLA2G6-related parkinsonism in a longitudinal study. Background: There is a paucity of follow-up studies on disease progression in PLA2G6-related…Eye movements and cognitive function
Objective: find out the relationship between eye movements and cognitive function (CF). Background: working in our clinic we have learned to give a pre-assessment of…Cognitive Performance in Early Neuronal alpha-Synuclein Disease
Objective: To determine if cognitive deficits can be detected in early-stage Neuronal alpha-Synuclein Disease (NSD) compared with healthy controls. Background: Global cognitive deficits have been…Clinical and neurological features of the course of Parkinsonism disease in patients with CKD with cystatin C disorder
Objective: To study the effect of cystatin C on the development of cognitive disorders(CD) in patients with CKD(Chronic kidney disease) and vascular parkinsonism Background: Clinical…Perspective of people living with early Parkinson’s Disease: most common, burdensome, and worrisome symptoms
Objective: To assess the most common, burdensome and worrisome symptoms experienced by people living with early Parkinson’s Disease (ePD). Background: Research on symptom frequency and…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 117
- Next Page »